{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:22:49Z","timestamp":1790515369483,"version":"4.1.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,7]],"date-time":"2022-12-07T00:00:00Z","timestamp":1670371200000},"content-version":"vor","delay-in-days":2107,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Next Generation World-leading Researchers","award":["NEXT Program; LS052"],"award-info":[{"award-number":["NEXT Program; LS052"]}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1111\/jth.13604","type":"journal-article","created":{"date-parts":[[2016,12,27]],"date-time":"2016-12-27T20:56:46Z","timestamp":1482872206000},"page":"513-525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["C\u2010type lectin\u2010like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor\u2010bearing mice"],"prefix":"10.1016","volume":"15","author":[{"given":"T.","family":"Shirai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O.","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Tamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Tsukiji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Endo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Osada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Sato\u2010Uchida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Fujii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y.","family":"Ozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Suzuki\u2010Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/jth.13604_bb0010","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S1470-2045(02)00789-1","article-title":"Platelets and cancer","volume":"3","author":"Nash","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1111\/jth.13604_bb0015","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","article-title":"Platelet\u2010cancer interactions: mechanisms and pharmacology of tumour cell\u2010induced platelet aggregation","volume":"143","author":"Jurasz","year":"2004","journal-title":"Br J Pharmacol"},{"key":"10.1111\/jth.13604_bb0020","first-page":"1295","article-title":"Lysis of tumor cells by natural killer cells in mice is impeded by platelets","volume":"59","author":"Nieswandt","year":"1999","journal-title":"Cancer Res"},{"key":"10.1111\/jth.13604_bb0025","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/ijc.27441","article-title":"Tumor\u2010platelet interaction in solid tumors","volume":"130","author":"Buergy","year":"2012","journal-title":"Int J Cancer"},{"key":"10.1111\/jth.13604_bb0030","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/09537109509078458","article-title":"Mechanisms of the platelet proaggregating activity of human carcinoma a431 cells","volume":"6","author":"Pulcinelli","year":"1995","journal-title":"Platelets"},{"key":"10.1111\/jth.13604_bb0035","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0038-1642691","article-title":"Role of platelets, thrombin, integrin IIb\u2010IIIa, fibronectin and von Willebrand factor on tumor adhesion in vitro and metastasis in vivo","volume":"74","author":"Nierodzik","year":"1995","journal-title":"Thromb Haemost"},{"key":"10.1111\/jth.13604_bb0040","first-page":"2997","article-title":"The role of podoplanin in tumor progression and metastasis","volume":"28","author":"Raica","year":"2008","journal-title":"Anticancer Res"},{"issue":"Suppl 1","key":"10.1111\/jth.13604_bb0045","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/j.1538-7836.2011.04335.x","article-title":"Novel platelet activation receptor CLEC\u20102: from discovery to prospects","volume":"9","author":"Suzuki\u2010Inoue","year":"2011","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13604_bb0050","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/cup.12322","article-title":"Podoplanin expression in cancer\u2010associated fibroblasts predicts aggressive behavior in melanoma","volume":"41","author":"Kan","year":"2014","journal-title":"J Cutan Pathol"},{"key":"10.1111\/jth.13604_bb0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s00401-006-0063-y","article-title":"Increased expression of podoplanin in malignant astrocytic tumors as a novel molecular marker of malignant progression","volume":"111","author":"Mishima","year":"2006","journal-title":"Acta Neuropathol"},{"key":"10.1111\/jth.13604_bb0060","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1182\/blood-2005-05-1994","article-title":"A novel Syk\u2010dependent mechanism of platelet activation by the C\u2010type lectin receptor CLEC\u20102","volume":"107","author":"Suzuki\u2010Inoue","year":"2006","journal-title":"Blood"},{"key":"10.1111\/jth.13604_bb0065","doi-asserted-by":"crossref","first-page":"25993","DOI":"10.1074\/jbc.M702327200","article-title":"Involvement of the snake toxin receptor CLEC\u20102, in podoplanin\u2010mediated platelet activation, by cancer cells","volume":"282","author":"Suzuki\u2010Inoue","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13604_bb0070","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/eji.201141641","article-title":"CLEC\u20102 signaling via Syk in myeloid cells can regulate inflammatory responses","volume":"41","author":"Mourao\u2010Sa","year":"2011","journal-title":"Eur J Immunol"},{"key":"10.1111\/jth.13604_bb0075","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1182\/blood-2009-05-222273","article-title":"CLEC\u20102 is an essential platelet\u2010activating receptor in hemostasis and thrombosis","volume":"114","author":"May","year":"2009","journal-title":"Blood"},{"key":"10.1111\/jth.13604_bb0080","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1161\/ATVBAHA.112.300672","article-title":"Combined in vivo depletion of glycoprotein VI and C\u2010type lectin\u2010like receptor 2 severely compromises hemostasis and abrogates arterial thrombosis in mice","volume":"33","author":"Bender","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1111\/jth.13604_bb0085","first-page":"24494","article-title":"Essential in vivo roles of the C\u2010type lectin receptor CLEC\u20102: embryonic\/neonatal lethality of CLEC\u20102\u2010deficient mice by blood\/lymphatic misconnections and impaired thrombus formation of CLEC\u20102\u2010deficient platelets","volume":"285","author":"Suzuki\u2010Inoue","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13604_bb0090","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1111\/j.1538-7836.2010.04006.x","article-title":"CLEC\u20102 is not required for platelet aggregation at arteriolar shear","volume":"8","author":"Hughes","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13604_bb0095","doi-asserted-by":"crossref","first-page":"3546","DOI":"10.1093\/emboj\/cdg342","article-title":"T1alpha\/podoplanin deficiency disrupts normal lymphatic vasculature formation and causes lymphedema","volume":"22","author":"Schacht","year":"2003","journal-title":"EMBO J"},{"key":"10.1111\/jth.13604_bb0100","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/ni.3035","article-title":"The CLEC\u20102\u2010podoplanin axis controls the contractility of fibroblastic reticular cells and lymph node microarchitecture","volume":"16","author":"Astarita","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1111\/jth.13604_bb0105","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1349-7006.2007.00634.x","article-title":"Molecular analysis of the pathophysiological binding of the platelet aggregation\u2010inducing factor podoplanin to the C\u2010type lectin\u2010like receptor CLEC\u20102","volume":"99","author":"Kato","year":"2008","journal-title":"Cancer Sci"},{"key":"10.1111\/jth.13604_bb0110","doi-asserted-by":"crossref","first-page":"e0139357","DOI":"10.1371\/journal.pone.0139357","article-title":"Vascular smooth muscle cells stimulate platelets and facilitate thrombus formation through platelet CLEC\u20102: implications in atherothrombosis","volume":"10","author":"Inoue","year":"2015","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13604_bb0115","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1182\/blood-2015-08-663708","article-title":"Podoplanin\u2010positive periarteriolar stromal cells promote megakaryocyte growth and proplatelet formation in mice by CLEC\u20102","volume":"127","author":"Tamura","year":"2016","journal-title":"Blood"},{"key":"10.1111\/jth.13604_bb0120","doi-asserted-by":"crossref","first-page":"22241","DOI":"10.1074\/jbc.M111.329987","article-title":"Platelet activation receptor CLEC\u20102 regulates blood\/lymphatic vessel separation by inhibiting proliferation, migration, and tube formation of lymphatic endothelial cells","volume":"287","author":"Osada","year":"2012","journal-title":"J Biol Chem"},{"key":"10.1111\/jth.13604_bb0125","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1182\/blood-2014-11-611905","article-title":"Targeted downregulation of platelet CLEC\u20102 occurs through Syk\u2010independent internalization","volume":"125","author":"Lorenz","year":"2015","journal-title":"Blood"},{"key":"10.1111\/jth.13604_bb0130","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.immuni.2012.05.022","article-title":"Podoplanin\u2010rich stromal networks induce dendritic cell motility via activation of the C\u2010type lectin receptor CLEC\u20102","volume":"37","author":"Acton","year":"2012","journal-title":"Immunity"},{"key":"10.1111\/jth.13604_bb0135","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1053\/j.seminoncol.2014.04.006","article-title":"Platelets effects on tumor growth","volume":"41","author":"Goubran","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1111\/jth.13604_bb0140","first-page":"189","article-title":"The role of blood platelets in tumor angiogenesis","volume":"1815","author":"Sabrkhany","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"10.1111\/jth.13604_bb0145","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0002-9440(10)61690-2","article-title":"Selective thrombosis of tumor blood vessels in mammary adenocarcinoma implants in rats","volume":"159","author":"Samoszuk","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.13604_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.tvjl.2014.03.021","article-title":"Immunohistochemical evaluation of tissue factor, fibrin\/fibrinogen and D\u2010dimers in canine gliomas","volume":"200","author":"de la Fuente","year":"2014","journal-title":"Vet J"},{"key":"10.1111\/jth.13604_bb0155","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1538-7836.2007.02374.x","article-title":"Thromboembolism is a leading cause of death in cancer patients receiving outpatient chemotherapy","volume":"5","author":"Khorana","year":"2007","journal-title":"J Thromb Haemost"},{"key":"10.1111\/jth.13604_bb0160","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1053\/j.seminoncol.2014.04.005","article-title":"Therapy for cancer\u2010related thromboembolism","volume":"41","author":"Frere","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1111\/jth.13604_bb0165","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.blre.2006.06.001","article-title":"Platelet\u2010neutrophil\u2010interactions: linking hemostasis and inflammation","volume":"21","author":"Zarbock","year":"2007","journal-title":"Blood Rev"},{"key":"10.1111\/jth.13604_bb0170","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1111\/jth.13604_bb0175","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrc967","article-title":"Metastasis suppressors alter the signal transduction of cancer cells","volume":"3","author":"Steeg","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1111\/jth.13604_bb0180","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/nm0603-713","article-title":"Imaging of angiogenesis: from microscope to clinic","volume":"9","author":"McDonald","year":"2003","journal-title":"Nat Med"},{"key":"10.1111\/jth.13604_bb0185","doi-asserted-by":"crossref","first-page":"115","DOI":"10.3389\/fonc.2012.00115","article-title":"Do circulating tumor cells play a role in coagulation and thrombosis?","volume":"2","author":"Tormoen","year":"2012","journal-title":"Front Oncol"},{"key":"10.1111\/jth.13604_bb0190","first-page":"587","article-title":"The selection and characterization of an invasive variant of the B16 melanoma","volume":"97","author":"Hart","year":"1979","journal-title":"Am J Pathol"},{"key":"10.1111\/jth.13604_bb0195","doi-asserted-by":"crossref","first-page":"e56557","DOI":"10.1371\/journal.pone.0056557","article-title":"Holothurian glycosaminoglycan inhibits metastasis and thrombosis via targeting of nuclear factor\u2010kappaB\/tissue factor\/Factor Xa pathway in melanoma B16F10 cells","volume":"8","author":"Zhao","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/jth.13604_bb0200","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nri910","article-title":"NF\u2010kappaB regulation in the immune system","volume":"2","author":"Li","year":"2002","journal-title":"Nat Rev Immunol"},{"key":"10.1111\/jth.13604_bb0205","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1634\/theoncologist.11-4-397","article-title":"TNF\u2010alpha in cancer treatment: molecular insights, antitumor effects, and clinical utility","volume":"11","author":"van Horssen","year":"2006","journal-title":"Oncologist"},{"key":"10.1111\/jth.13604_bb0210","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.ctrv.2012.04.007","article-title":"Interleukin\u20106 signaling pathway in targeted therapy for cancer","volume":"38","author":"Guo","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1111\/jth.13604_bb0215","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/S0140-6736(12)60209-8","article-title":"Effect of daily aspirin on risk of cancer metastasis: a study of incident cancers during randomised controlled trials","volume":"379","author":"Rothwell","year":"2012","journal-title":"Lancet"},{"key":"10.1111\/jth.13604_bb0220","doi-asserted-by":"crossref","first-page":"10846","DOI":"10.1038\/srep10846","article-title":"A novel direct factor Xa inhibitory peptide with anti\u2010platelet aggregation activity from agkistrodon acutus venom hydrolysates","volume":"5","author":"Chen","year":"2015","journal-title":"Sci Rep"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjth.13604","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622035887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/jth.13604\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T03:18:37Z","timestamp":1761535117000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622035887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S1538783622035887"],"URL":"https:\/\/doi.org\/10.1111\/jth.13604","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"C\u2010type lectin\u2010like receptor 2 promotes hematogenous tumor metastasis and prothrombotic state in tumor\u2010bearing mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/jth.13604","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}